Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03334493
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
RNP | (1E,2R)-1-(ISOPROPYLIMINO)-3-(1- NAPHTHYLOXY)PROPAN-2-OL | X | 1H46 | 0.72 |  |
NLX | (5A,17R)-4,5-EPOXY-3,14-DIHYDROXY- 17-METHYL-6-OXO-17-(2-PROPENYL)- MORPHINANIUM | A,B,C,D,E,F, G,H,I,J,K,L | 1MX9 | 0.73 | |
GNT | (-)-GALANTHAMINE | A | 1DX6 | 0.77 | |
| GNT | (-)-GALANTHAMINE | A | 1QTI | 0.77 | |
| GNT | (-)-GALANTHAMINE | A,B,C,D,E | 2PH9 | 0.77 | |
| GNT | (-)-GALANTHAMINE | A,B | 1W76 | 0.77 | |
| GNT | (-)-GALANTHAMINE | A | 1W6R | 0.77 | |
5PP | 5-PENTYL-2-PHENOXYPHENOL | A,B,C,D,E,F | 2B36 | 0.76 | |
EGT | 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN- 3,5,7-TRIOL | A | 1JNQ | 0.71 | |
C41 | ALISKIREN | C,O | 2V0Z | 0.7 | |
8PS | 5-OCTYL-2-PHENOXYPHENOL | A,B,C,D,E,F | 2B37 | 0.76 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.74 | |
| ALE | L-EPINEPHRINE | A | 2HKK | 0.74 | |
EUG | 2-METHOXY-4-VINYL-PHENOL | A | 2QU9 | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1QLU | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1W1J | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 2VAO | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1W1K | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1DZN | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1W1L | 0.73 | |
| EUG | 2-METHOXY-4-VINYL-PHENOL | A,B | 1W1M | 0.73 | |
261 | 2-ethoxyphenol | X | 2RB1 | 0.7 | |
C3D | (5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN- 1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN- 2-OL | A | 2OUZ | 0.76 | |
SLX | (13aS)-3,10-dimethoxy-5,8,13,13a- tetrahydro-6H-isoquino[3,2-a]isoquinoline- 2,9-diol | A | 3FW9 | 0.83 | |
8CM | 8-HYDROXYCOUMARIN | A | 2H8Z | 0.71 | |
OHT | 4-HYDROXYTAMOXIFEN | A | 3ERT | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B | 1S9Q | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B | 1VJB | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B,C,P,R | 2JF9 | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B,C,D,E,F | 2GPV | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A | 2GPU | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A | 2P7Z | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B | 2BJ4 | 0.77 | |
| OHT | 4-HYDROXYTAMOXIFEN | A,B | 2FSZ | 0.77 | |
PTI | 2-PHENYL-1-[4-(2-PIPERIDIN-1-YL- ETHOXY)-PHENYL]-1,2,3,4-TETRAHYDRO- ISOQUINOLIN-6-OL | A | 1UOM | 0.73 | |
P14 | N-[2-(2-{[(4-{[AMINO(IMINO)METHYL]AMINO}BUTYL)AMINO]METHYL}- 4-METHOXYPHENOXY)ETHYL]GUANIDINE | B | 1UUD | 0.7 | |
AHF | 2-[4-(HYDROXY-METHOXY-METHYL)-BENZYL]- 7-(4-HYDROXYMETHYL-BENZYL)-1,1- DIOXO-3,6-BIS-PHENOXYMETHYL-1LAMBDA6- [1,2,7]THIADIAZEPANE-4,5-DIOL | B | 1G35 | 0.71 | |
REN | (S)-reticuline | A | 3FWA | 0.84 | |
| REN | (S)-reticuline | A | 3D2D | 0.84 | |
2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OTF | 0.73 | |
| 2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2NUV | 0.73 | |
| 2TN | 2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE | A | 2OUB | 0.73 | |
XX7 | 2-{[(2S)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE- 1,3-DIOL | A | 2V3R | 0.72 | |
XX6 | 2-{[(2R)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE- 1,3-DIOL | A | 2V3I | 0.72 | |
5RM | (5R)-5-(4-methoxy-3-propoxyphenyl)- 5-methyl-1,3-oxazolidin-2-one | A,B | 1XM6 | 0.73 | |
505 | (2R)-1-(2,6-dimethylphenoxy)propan- 2-amine | A | 2VIN | 0.71 | |
CM3 | (2R,3R,4S)-5-FLUORO-3-(4-HYDROXYPHENYL)- 4-METHYL-2-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]CHROMAN- 6-OL | A | 1YIN | 0.75 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.71 | |
| LDP | L-DOPAMINE | A | 5PAH | 0.71 | |
| LDP | L-DOPAMINE | A,B | 2QMZ | 0.71 | |
| LDP | L-DOPAMINE | A,B | 2VQ5 | 0.71 | |
C61 | (2R,4S,5S,7S)-5-AMINO-N-BUTYL-4- HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]- 2,8-DIMETHYLNONANAMIDE | C,O | 2V10 | 0.71 | |
NMB | 2,7-DIBENZYL-1,1-DIOXO-3,6-BIS- PHENOXYMETHYL-[1,2,7]THIADIAZEPANE- 4,5-DIOL | A | 1AJV | 0.71 | |
TXF | (Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}- 5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL | A,B,C,D,E | 2EWP | 0.77 | |
DPD | A,B | 1QIW | 0.75 | | |
| DPD | A | 1QIV | 0.75 | | |
A88 | (5R,6R)-2,4-BIS-(4-HYDROXY-3-METHOXYBENZYL)- 1,5-DIBENZYL-3-OXO-6-HYDROXY-1,2,4- TRIAZACYCLOHEPTANE | A | 1PRO | 0.73 | |
TAX | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)- PHENOXY]-N,N-DIMETHYLETHANAMINIUM | A | 1FJ5 | 0.7 | |
CMZ | (2S)-1-(2,5-dimethylphenoxy)-3- morpholin-4-ylpropan-2-ol | A | 2OF0 | 0.82 | |
MOI | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A- HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2- E]ISOQUINOLINE-7,9-DIOL | H,L | 1Q0Y | 0.79 | |
SNP | 1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)- 2-PROPANOL | A | 1DY4 | 0.77 | |
CM4 | (2R,3R,4S)-3-(4-HYDROXYPHENYL)- 4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN- 6-OL | A | 1YIM | 0.76 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.72 | |
| SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.72 | |
LNR | L-NOREPINEPHRINE | A,B | 2QEO | 0.7 | |
| LNR | L-NOREPINEPHRINE | A | 3DYE | 0.7 | |
| LNR | L-NOREPINEPHRINE | A | 4PAH | 0.7 | |
CTX | (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)- PHENOXY]-N,N-DIMETHYLETHANAMINE | A,B,C | 1YA4 | 0.73 | |
ANM | ANISOMYCIN | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1K73 | 0.75 | |
| ANM | ANISOMYCIN | 0,1,3,9,A,B, C,F,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3CC4 | 0.75 | |